Next 10 |
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
2024-06-28 07:15:57 ET Summary Accolade's full-year guidance was mixed, notwithstanding a Q1 FY 2025 results beat driven by a favorable timing factor. ACCD sees its revenue growth slowing from +14% last year to +13% in the current fiscal year, but its 3.7% FY 2025 EBITDA margin gu...
2024-06-28 07:00:08 ET Stephanie Davis from Barclays issued a price target of $5.50 for ACCD on 2024-06-28 05:31:00. The adjusted price target was set to $5.50. At the time of the announcement, ACCD was trading at $6.39. The overall price target consensus is at $19.22 wi...
2024-06-28 05:34:02 ET More on related stocks: Accolade, Inc. (ACCD) Q1 2025 Earnings Call Transcript NIKE, Inc. (NKE) Q4 2024 Earnings Call Transcript Accolade, Inc. 2025 Q1 - Results - Earnings Call Presentation Nike cuts revenue growth forecasts as macro h...
2024-06-27 19:24:07 ET Accolade, Inc. (ACCD) Q1 2025 Earnings Conference Call June 27, 2024, 04:30 PM ET Company Participants Todd Friedman - SVP of IR Rajeev Singh - CEO Steve Barnes - CFO Conference Call Participants Richard Close - Canaccord Genuit...
2024-06-27 16:05:43 ET More on Accolade Accolade, Inc. (ACCD) Q4 2024 Earnings Call Transcript Accolade: Staying Bullish On Favorable Developments Accolade Q1 2025 Earnings Preview Earnings week ahead: FedEx, Nike, Carnival, Micron, BlackBerry, Walgreens Boot...
SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
2024-06-26 17:35:58 ET More on Accolade Accolade, Inc. (ACCD) Q4 2024 Earnings Call Transcript Accolade: Staying Bullish On Favorable Developments Earnings week ahead: FedEx, Nike, Carnival, Micron, BlackBerry, Walgreens Boots, and more Seeking Alpha’s...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
2024-06-28 07:00:08 ET Stephanie Davis from Barclays issued a price target of $5.50 for ACCD on 2024-06-28 05:31:00. The adjusted price target was set to $5.50. At the time of the announcement, ACCD was trading at $6.39. The overall price target consensus is at $19.22 wi...